Integration of Immuno-Oncology to Improve HCC Outcomes: Immune Checkpoint Inhibition and Potential Synergies with Interventional Radiology and Radiation Oncology

Laura M. Kulik, MD

Supported by educational grants from Bristol-Myers Squibb, Eisai and Merck.

This recorded webinar is for educational purposes only and is non-accredited.